Inari Medical, Inc.
NARI · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $3,685,551 | $3,358,363 | $4,546,698 | $2,796,233 |
| - Cash | $38,597 | $60,222 | $92,752 | $114,229 |
| + Debt | $32,047 | $32,287 | $29,206 | $0 |
| Enterprise Value | $3,679,001 | $3,330,428 | $4,483,152 | $2,682,004 |
| Revenue | $493,632 | $383,471 | $276,984 | $139,670 |
| % Growth | 28.7% | 38.4% | 98.3% | – |
| Gross Profit | $434,564 | $338,965 | $252,227 | $126,564 |
| % Margin | 88% | 88.4% | 91.1% | 90.6% |
| EBITDA | $15,187 | -$18,254 | $15,510 | $16,409 |
| % Margin | 3.1% | -4.8% | 5.6% | 11.7% |
| Net Income | -$1,636 | -$29,267 | $9,840 | $13,789 |
| % Margin | -0.3% | -7.6% | 3.6% | 9.9% |
| EPS Diluted | -0.029 | -0.55 | 0.18 | 0.27 |
| % Growth | 94.8% | -405.6% | -33.3% | – |
| Operating Cash Flow | $35,927 | -$13,972 | $25,486 | $1,912 |
| Capital Expenditures | -$6,201 | -$9,951 | -$13,645 | -$5,460 |
| Free Cash Flow | $29,726 | -$23,923 | $11,841 | -$3,548 |